Market Closed -
Hong Kong S.E.
04:08:27 2024-07-12 am EDT
|
5-day change
|
1st Jan Change
|
10.8
HKD
|
+2.66%
|
|
-0.74%
|
-39.19%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
54,224
|
90,769
|
26,143
|
21,047
|
18,060
|
10,941
|
-
|
-
|
Enterprise Value (EV)
1 |
48,779
|
80,952
|
23,078
|
17,346
|
16,194
|
8,757
|
8,471
|
7,859
|
P/E ratio
|
-69.6
x
|
-86
x
|
-16.6
x
|
-33.6
x
|
-53.8
x
|
-53.7
x
|
-2,802
x
|
179
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
10.7
x
|
13.2
x
|
3.56
x
|
3.42
x
|
3.86
x
|
2.04
x
|
1.77
x
|
1.64
x
|
EV / Revenue
|
9.63
x
|
11.8
x
|
3.15
x
|
2.82
x
|
3.46
x
|
1.63
x
|
1.37
x
|
1.18
x
|
EV / EBITDA
|
-59.9
x
|
-108
x
|
-16.1
x
|
-31.9
x
|
-36
x
|
-27
x
|
-74.9
x
|
138
x
|
EV / FCF
|
-76.5
x
|
-68.9
x
|
-15.5
x
|
-20.5
x
|
-49.7
x
|
-33.5
x
|
303
x
|
37
x
|
FCF Yield
|
-1.31%
|
-1.45%
|
-6.47%
|
-4.87%
|
-2.01%
|
-2.99%
|
0.33%
|
2.7%
|
Price to Book
|
5.62
x
|
5.73
x
|
1.88
x
|
1.56
x
|
1.36
x
|
0.83
x
|
0.84
x
|
0.81
x
|
Nbr of stocks (in thousands)
|
1,067,294
|
1,147,294
|
1,131,742
|
1,118,813
|
1,118,813
|
1,118,813
|
-
|
-
|
Reference price
2 |
50.81
|
79.12
|
23.10
|
18.81
|
16.14
|
9.780
|
9.780
|
9.780
|
Announcement Date
|
2/11/20
|
2/2/21
|
3/15/22
|
3/13/23
|
3/19/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,065
|
6,866
|
7,334
|
6,160
|
4,674
|
5,372
|
6,173
|
6,654
|
EBITDA
1 |
-813.7
|
-749.4
|
-1,437
|
-544
|
-449.4
|
-324.6
|
-113.2
|
57.03
|
EBIT
1 |
-959.4
|
-919.1
|
-1,643
|
-697.8
|
-575.3
|
-362.9
|
-166.6
|
48.27
|
Operating Margin
|
-18.94%
|
-13.39%
|
-22.41%
|
-11.33%
|
-12.31%
|
-6.76%
|
-2.7%
|
0.73%
|
Earnings before Tax (EBT)
1 |
-734.1
|
-941.3
|
-1,524
|
-607.7
|
-331.9
|
-232.6
|
-25.67
|
169.3
|
Net income
1 |
-733.9
|
-948.5
|
-1,538
|
-607.6
|
-322.6
|
-199.1
|
2.974
|
92.86
|
Net margin
|
-14.49%
|
-13.81%
|
-20.97%
|
-9.86%
|
-6.9%
|
-3.71%
|
0.05%
|
1.4%
|
EPS
2 |
-0.7300
|
-0.9200
|
-1.390
|
-0.5600
|
-0.3000
|
-0.1822
|
-0.003490
|
0.0547
|
Free Cash Flow
1 |
-637.2
|
-1,175
|
-1,492
|
-845.1
|
-325.8
|
-261.7
|
28
|
212.3
|
FCF margin
|
-12.58%
|
-17.12%
|
-20.35%
|
-13.72%
|
-6.97%
|
-4.87%
|
0.45%
|
3.19%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
372.29%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
941.63%
|
228.67%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/11/20
|
2/2/21
|
3/15/22
|
3/13/23
|
3/19/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
2,747
|
4,119
|
3,818
|
3,516
|
2,828
|
3,332
|
2,222
|
2,451
|
2,111
|
2,249
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-988.4
|
-706.2
|
-461.8
|
-236.1
|
-357.1
|
-218.2
|
-
|
-
|
Operating Margin
|
-
|
-
|
-25.89%
|
-20.09%
|
-16.33%
|
-7.09%
|
-16.07%
|
-8.9%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-652.9
|
-
|
-
|
-244.3
|
-87.63
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-244.6
|
-77.98
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-11.01%
|
-3.18%
|
-
|
-
|
EPS
|
-
|
-
|
-0.8000
|
-0.5900
|
-0.3900
|
-0.1700
|
-0.2300
|
-0.0700
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/24/21
|
2/2/21
|
8/24/21
|
3/15/22
|
8/18/22
|
3/13/23
|
8/24/23
|
3/19/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
5,445
|
9,816
|
3,065
|
3,701
|
1,867
|
2,184
|
2,471
|
3,083
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-637
|
-1,175
|
-1,492
|
-845
|
-326
|
-262
|
28
|
212
|
ROE (net income / shareholders' equity)
|
-7.39%
|
-7.44%
|
-10.3%
|
-4.41%
|
-2.41%
|
-1.53%
|
-0.07%
|
0.72%
|
ROA (Net income/ Total Assets)
|
-5.93%
|
-6.13%
|
-8.44%
|
-3.47%
|
-0.79%
|
-1.52%
|
-0.29%
|
0.15%
|
Assets
1 |
12,376
|
15,471
|
18,222
|
17,511
|
40,886
|
13,119
|
-1,037
|
61,905
|
Book Value Per Share
2 |
9.040
|
13.80
|
12.30
|
12.00
|
11.90
|
11.80
|
11.60
|
12.00
|
Cash Flow per Share
2 |
-0.5000
|
-1.070
|
-1.270
|
-0.7500
|
-0.2600
|
0.0900
|
0.2500
|
0.4800
|
Capex
1 |
133
|
73.2
|
89.2
|
34.4
|
43
|
54.4
|
58.1
|
66.3
|
Capex / Sales
|
2.63%
|
1.07%
|
1.22%
|
0.56%
|
0.92%
|
1.01%
|
0.94%
|
1%
|
Announcement Date
|
2/11/20
|
2/2/21
|
3/15/22
|
3/13/23
|
3/19/24
|
-
|
-
|
-
|
Last Close Price
9.78
CNY Average target price
15.93
CNY Spread / Average Target +62.91% Consensus |
1st Jan change
|
Capi.
|
---|
| -39.19% | 1.51B | | +17.30% | 83.16B | | -26.28% | 73.08B | | -1.34% | 26.15B | | +4.38% | 17.9B | | -9.26% | 17.39B | | +4.08% | 15.94B | | +76.90% | 13.61B | | +76.96% | 13.06B | | -25.96% | 12.76B |
Other Healthcare Facilities & Services
|